- Conditions
- Cardiac Arrhythmia, Atrial Fibrillation, Ventricular Arrythmia, Premature Ventricular Complexes Multiple, Ventricular Tachycardia, Ventricular Fibrillation, Premature Atrial Complex, Atrioventricular Reentrant Tachycardia
- Interventions
- Cardiac ablation procedure
- Device
- Lead sponsor
- Vektor Medical
- Industry
- Eligibility
- 22 Years to 100 Years
- Enrollment
- 225 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 4
- States / cities
- Charleston, California • La Jolla, California • San Diego, California + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–8
of 8
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- AtrioVentricular Nodal Reentrant Tachycardia, Supraventricular Tachycardia, Heart Disease
- Interventions
- Freezor Xtra Cryoablation Catheter
- Device
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 572 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 26
- States / cities
- Phoenix, Arizona • Santa Monica, California • Stanford, California + 23 more
- Conditions
- Supraventricular Tachycardia
- Interventions
- New Ablation Technique, Standard Ablation Technique
- Procedure
- Lead sponsor
- Jeffrey Moak
- Other
- Eligibility
- Up to 21 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 5
- States / cities
- Washington D.C., District of Columbia • Hollywood, Florida • Iowa City, Iowa + 2 more
- Conditions
- Tachycardia, Atrioventricular Nodal Reentry
- Interventions
- Freezor® Cardiac Cryoablation Catheter CryoConsole System
- Device
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 105 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2013
- U.S. locations
- 4
- States / cities
- Minneapolis, Minnesota • Omaha, Nebraska • New York, New York + 1 more
- Conditions
- Paroxysmal Supraventricular Tachycardia
- Interventions
- Etripamil, Placebo, Etripamil Test Dose
- Drug
- Lead sponsor
- Milestone Pharmaceuticals Inc.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,097 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2023
- U.S. locations
- 54
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • Cerritos, California + 44 more
- Conditions
- Atrial Flutter, Tachycardia, Supraventricular, Tachycardia, Atrial Ectopic, Tachycardia, Reciprocating, Tachycardia Atrial, Tachycardia, Atrioventricular Nodal Reentry, Tachycardia, Paroxysmal, Fetal Hydrops
- Interventions
- Prospective observational cohorts
- Other
- Lead sponsor
- Edgar Jaeggi
- Other
- Eligibility
- 16 Years to 50 Years · Female only
- Enrollment
- 330 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2025
- U.S. locations
- 18
- States / cities
- Phoenix, Arizona • San Francisco, California • Denver, Colorado + 15 more
- Conditions
- Paroxysmal Supraventricular Tachycardia
- Interventions
- Etripamil NS 70 mg, Aptar Pharma Nasal Spray Bidose System
- Drug · Device
- Lead sponsor
- Milestone Pharmaceuticals Inc.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 169 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 22
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • Los Alamitos, California + 18 more
- Conditions
- Tachycardia, Atrioventricular Nodal Reentry
- Interventions
- Cardiac Invasive Electrophysiological Study
- Procedure
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- 16 Years to 80 Years
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2021
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma